Importantly from a therapeutic point of view, multiple studies have demonstrated that utrophin upregulation using a variety of different means (e.g. transgenic, viral vectors, pharmacological) can functionally rescue the dystrophic phenotype in the mdx mouse model of DMD [17–21]. Here, UTRN is linked to Duchenne muscular dystrophy.